Fresenius Medical Care AG & Co KGaA, a kidney dialysis company, provides dialysis care and related services, and other health care services in Germany, the United States, and internationally. It offers dialysis treatment and related laboratory and diagnostic services through a network of outpatient dialysis clinics; materials, training, and patient support services comprising clinical monitoring, follow-up assistance, and arranging for delivery of the supplies to the patient's residence; and dialysis services under contract to hospitals in the United States for the hospitalized end-stage renal disease (ESRD) patients and for patients suffering from acute kidney failure.
Read More…
Industry, Sector and Symbol
Industry Medical Care
Sub-IndustryN/A
SectorMedical
CIKN/A
Phone+49-6172-6090
Debt
Price-To-Earnings
Sales & Book Value
Annual Sales$16.84 billion
Profitability
Miscellaneous
Employees112,658
Next Earnings Date10/29/2019 (Estimated)
OptionableNot Optionable
Fresenius Medical Care AG & Co. KGaA (ETR:FME) Frequently Asked Questions
What is Fresenius Medical Care AG & Co. KGaA's stock symbol?
Fresenius Medical Care AG & Co. KGaA trades on the ETR under the ticker symbol "FME."
When is Fresenius Medical Care AG & Co. KGaA's next earnings date?
What price target have analysts set for FME?
17 analysts have issued 1-year price targets for Fresenius Medical Care AG & Co. KGaA's stock. Their forecasts range from €58.00 to €100.00. On average, they expect Fresenius Medical Care AG & Co. KGaA's stock price to reach €79.03 in the next year. This suggests a possible upside of 28.4% from the stock's current price. View Analyst Price Targets for Fresenius Medical Care AG & Co. KGaA.
What is the consensus analysts' recommendation for Fresenius Medical Care AG & Co. KGaA?
17 Wall Street analysts have issued "buy," "hold," and "sell" ratings for Fresenius Medical Care AG & Co. KGaA in the last year. There are currently 7 hold ratings and 10 buy ratings for the stock, resulting in a consensus recommendation of "Buy." View Analyst Ratings for Fresenius Medical Care AG & Co. KGaA.
Has Fresenius Medical Care AG & Co. KGaA been receiving favorable news coverage?
Media headlines about FME stock have been trending somewhat positive recently, InfoTrie Sentiment reports. InfoTrie scores the sentiment of media coverage by reviewing more than six thousand news and blog sources. The firm ranks coverage of public companies on a scale of negative five to positive five, with scores closest to five being the most favorable. Fresenius Medical Care AG & Co. KGaA earned a news sentiment score of 0.8 on InfoTrie's scale. They also assigned news coverage about the company a news buzz of 0.0 out of 10, indicating that recent media coverage is extremely unlikely to have an impact on the stock's share price in the immediate future. View News Stories for Fresenius Medical Care AG & Co. KGaA.
Who are some of Fresenius Medical Care AG & Co. KGaA's key competitors?
Some companies that are related to Fresenius Medical Care AG & Co. KGaA include Sonic Healthcare (SHL), NMC Health (NMC), Mediclinic International (MDC), Healius (HLS), Rhoen Klinikum (RHK), Spire Healthcare Group (SPI), CareTech (CTH), Virtus Health (VRT), Georgia Healthcare Group (GHG), Pacific Smiles Group (PSQ), Assure (IOM), CENTRIC HEALTH (CHH), Konekt (KKT), Totally (TLY) and Brain Resource (BRC).
What other stocks do shareholders of Fresenius Medical Care AG & Co. KGaA own?
Who are Fresenius Medical Care AG & Co. KGaA's key executives?
Fresenius Medical Care AG & Co. KGaA's management team includes the folowing people:
- Mr. Robert Maurice Powell Jr., Chairman of the Mgmt Board & CEO of Fresenius Medical Care Mgmt AG (Age 64)
- Mr. Michael Brosnan, CFO & Member of the Mgmt Board at Fresenius Medical Care Mgmt AG (Age 64)
- Mr. Kent Wanzek, CEO of Global Mfg & Quality & Member of Mgmt Board - Fresenius Medical Care Mgmt AG (Age 60)
- Dr. Olaf Schermeier, CEO of Global R&D and Member of the Mgmt Board - Fresenius Medical Care Mgmt AG (Age 47)
- Mr. Harry de Wit, CEO of APAC & Member of Mgmt Board - Fresenius Medical Care Mgmt AG (Age 57)
What is Fresenius Medical Care AG & Co. KGaA's stock price today?
One share of FME stock can currently be purchased for approximately €61.56.
How big of a company is Fresenius Medical Care AG & Co. KGaA?
What is Fresenius Medical Care AG & Co. KGaA's official website?
How can I contact Fresenius Medical Care AG & Co. KGaA?
Fresenius Medical Care AG & Co. KGaA's mailing address is Else-Kroener-Strasse 1, BAD HOMBURG, 61352, Germany. The company can be reached via phone at +49-6172-6090.
MarketBeat Community Rating for Fresenius Medical Care AG & Co. KGaA (ETR FME)
MarketBeat's community ratings are surveys of what our community members think about Fresenius Medical Care AG & Co. KGaA and other stocks. Vote "Outperform" if you believe FME will outperform the S&P 500 over the long term. Vote "Underperform" if you believe FME will underperform the S&P 500 over the long term. You may vote once every thirty days.
